|
DE151036C
(de)
|
|
|
|
|
|
DE150423C
(de)
|
|
|
|
|
|
US1889645A
(en)
|
1930-12-22 |
1932-11-29 |
Winthrop Chem Co Inc |
Beta-dimethylaminoethyl ester of para-butylamino-benzoic acid
|
|
US2441498A
(en)
|
1943-07-15 |
1948-05-11 |
Astra Apotekarnes Kem Fab |
Alkyl glycinanilides
|
|
US2689248A
(en)
|
1950-06-17 |
1954-09-14 |
Sterling Drug Inc |
Tertiary-aminoalkyl 4-amino-2-alkoxybenzoates and their synth esis
|
|
GB692332A
(en)
|
1950-07-18 |
1953-06-03 |
Geigy Ag J R |
Improvements relating to quaternary ammonium compounds, and their uses
|
|
US2774770A
(en)
|
1951-09-20 |
1956-12-18 |
Smith Kline French Lab |
Sulfur-containing amines
|
|
CH311614A
(de)
|
1952-02-25 |
1955-11-30 |
Cilag Ag |
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6-methyl-anilids).
|
|
CH311609A
(de)
|
1952-02-25 |
1955-11-30 |
Cilag Ag |
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6-methyl-anilids).
|
|
CH311613A
(de)
|
1952-02-25 |
1955-11-30 |
Cilag Ag |
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6-methyl-anilids).
|
|
CH311606A
(de)
|
1952-02-25 |
1955-11-30 |
Cilag Ag |
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6-methyl-anilids).
|
|
CH311611A
(de)
|
1952-02-25 |
1955-11-30 |
Cilag Ag |
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6-methyl-anilids).
|
|
CH311615A
(de)
|
1952-02-25 |
1955-11-30 |
Cilag Ag |
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6-methyl-anilids).
|
|
CH311608A
(de)
|
1952-02-25 |
1955-11-30 |
Cilag Ag |
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6-methyl-anilids).
|
|
CH311607A
(de)
|
1952-02-25 |
1955-11-30 |
Cilag Ag |
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6-methyl-anilids).
|
|
CH311610A
(de)
|
1952-02-25 |
1955-11-30 |
Cilag Ag |
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6-methyl-anilids).
|
|
CH311612A
(de)
|
1952-02-25 |
1955-11-30 |
Cilag Ag |
Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure-(2-halogen-6-methyl-anilids).
|
|
US2759975A
(en)
|
1952-05-28 |
1956-08-21 |
Gen Aniline & Film Corp |
Mixed alkyl-benzyl-alkylol quaternary ammonium salts
|
|
US2783230A
(en)
|
1953-03-16 |
1957-02-26 |
Hoffmann La Roche |
Derivatives of meta hydroxy aniline
|
|
GB751522A
(en)
|
1953-03-16 |
1956-06-27 |
Roche Products Ltd |
Novel derivatives of úÝ-hydroxy-aniline and the manufacture thereof
|
|
GB756538A
(en)
|
1953-12-24 |
1956-09-05 |
Bayer Ag |
Alkylation of aromatic amines
|
|
US2799679A
(en)
|
1955-04-28 |
1957-07-16 |
Bofors Ab |
Process of preparing amides of heterocyclic carboxylic acids
|
|
DE1018070B
(de)
*
|
1955-09-26 |
1957-10-24 |
Bayer Ag |
Verfahren zur Herstellung von anaesthetisch wirksamen N-Alkylaminocarbonsaeureaniliden
|
|
US2955111A
(en)
|
1957-01-28 |
1960-10-04 |
Bofors Ab |
Synthesis of n-alkyl-piperidine and n-alkyl-pyrrolidine-alpha-carboxylic acid amides
|
|
US3160662A
(en)
|
1957-06-26 |
1964-12-08 |
Astra Apotekarnes Kem Fab |
Lower alkylaminoacyl amide anesthetics
|
|
GB895601A
(en)
|
1957-11-20 |
1962-05-02 |
Sterling Drug Inc |
N[n-(monocarbocyclic aryl) carbamyl-lower-alkyl] amines and their preparation
|
|
DE1146872B
(de)
|
1959-01-29 |
1963-04-11 |
Bayer Ag |
Verfahren zur Herstellung von organischen Isocyanaten
|
|
US3049546A
(en)
|
1959-03-05 |
1962-08-14 |
Geigy Chem Corp |
Process for the decarbalkoxylation of alkyl esters of unsaturated, nitrogencontaining carboxylic acids
|
|
US3264309A
(en)
|
1959-08-24 |
1966-08-02 |
Sterling Drug Inc |
N' [nu-(monocarbocyclic aryl) carbamyllower-alkyl]-1, 5-iminocycloalkanes, -iminocycloalkenes and related compounds
|
|
US3080327A
(en)
|
1959-11-20 |
1963-03-05 |
T & H Smith Ltd |
Quaternary salts as denaturants for organic substances
|
|
NL281394A
(de)
|
1961-07-25 |
|
|
|
|
DE1251764B
(de)
|
1965-08-18 |
1967-10-12 |
C H Boehnnger Sohn Ingelheim/ Rhein |
Verfahren zur Herstellung von antimikrobiell wirksamen 12 3,4-Tetra hydro 9 -ammo acridmiumverbmdungen
|
|
GB1221061A
(en)
|
1967-01-18 |
1971-02-03 |
May & Baker Ltd |
Quaternary ammonium derivatives, their use as anthelmintics and methods for their preparation
|
|
US3574216A
(en)
|
1968-04-12 |
1971-04-06 |
American Home Prod |
Quaternary 3-pyridinium-2-quinolones
|
|
US3812147A
(en)
|
1970-12-22 |
1974-05-21 |
Astra Pharma Prod |
Acylxylidide local anaesthetics
|
|
US3931195A
(en)
|
1971-03-03 |
1976-01-06 |
Mead Johnson & Company |
Substituted piperidines
|
|
BE786875A
(fr)
|
1971-07-28 |
1973-01-29 |
Astra Pharma Prod |
Amide, methode pour sa preparation et ses compositions therapeutiques
|
|
US3773939A
(en)
|
1971-11-24 |
1973-11-20 |
Janssen Pharmaceutica Nv |
N-arallyl-n'-aralkyl piperazine pharmaceutical compositions
|
|
US4069309A
(en)
|
1972-09-19 |
1978-01-17 |
Avon Products, Inc. |
Cationic skin substantive sunscreen composition and method
|
|
US3900481A
(en)
|
1974-04-01 |
1975-08-19 |
Riker Laboratories Inc |
Derivatives of pyrrolidine and piperidine
|
|
US4005038A
(en)
|
1974-04-15 |
1977-01-25 |
Peerless Paint And Varnish Corporation |
Paint composition containing denatonium benzoate or lignocaine benzyl octanoate with a latex resin binder for application over old paint films to prevent ingestion of poisons therefrom
|
|
CS195321B2
(en)
|
1975-12-23 |
1980-01-31 |
Ciba Geigy Ag |
Plant growth suppressing agents
|
|
ZA767606B
(en)
|
1975-12-23 |
1977-11-30 |
Ciba Geigy Ag |
Compositions for influencing plant growth
|
|
US4070347A
(en)
|
1976-08-16 |
1978-01-24 |
Alza Corporation |
Poly(orthoester) co- and homopolymers and poly(orthocarbonate) co- and homopolymers having carbonyloxy functionality
|
|
US4147792A
(en)
|
1977-02-04 |
1979-04-03 |
Ciba-Geigy Corporation |
Fungicidal compositions
|
|
DE2915250A1
(de)
|
1979-04-14 |
1980-10-30 |
Basf Ag |
Salze von alpha -aminoacetaniliden
|
|
US4293539A
(en)
|
1979-09-12 |
1981-10-06 |
Eli Lilly And Company |
Controlled release formulations and method of treatment
|
|
US4877805A
(en)
|
1985-07-26 |
1989-10-31 |
Kligman Albert M |
Methods for treatment of sundamaged human skin with retinoids
|
|
US4757128A
(en)
|
1986-08-01 |
1988-07-12 |
Massachusetts Institute Of Technology |
High molecular weight polyanhydride and preparation thereof
|
|
US5169637A
(en)
|
1983-03-24 |
1992-12-08 |
The Liposome Company, Inc. |
Stable plurilamellar vesicles
|
|
CA1237671A
(en)
|
1983-08-01 |
1988-06-07 |
Michael W. Fountain |
Enhancement of pharmaceutical activity
|
|
WO1985000599A1
(en)
|
1983-08-01 |
1985-02-14 |
A/S Apothekernes Laboratorium For Specialpraeparat |
L-N-n-PROPYLPIPECOLIC ACID-2,6-XYLIDIDE AND METHOD FOR PREPARING THE SAME
|
|
US4975282A
(en)
|
1985-06-26 |
1990-12-04 |
The Liposome Company, Inc. |
Multilamellar liposomes having improved trapping efficiencies
|
|
US5409704A
(en)
|
1985-06-26 |
1995-04-25 |
The Liposome Company, Inc. |
Liposomes comprising aminoglycoside phosphates and methods of production and use
|
|
US5023087A
(en)
|
1986-02-10 |
1991-06-11 |
Liposome Technology, Inc. |
Efficient method for preparation of prolonged release liposome-based drug delivery system
|
|
IE60901B1
(en)
|
1986-08-21 |
1994-08-24 |
Vestar Inc |
Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
|
|
US5049388A
(en)
|
1986-11-06 |
1991-09-17 |
Research Development Foundation |
Small particle aerosol liposome and liposome-drug combinations for medical use
|
|
US5032582A
(en)
|
1987-02-27 |
1991-07-16 |
Liposome Technology, Inc. |
Method for treating fungal infections with amphotericin B/cholesterol sulfate composition
|
|
CS263363B1
(en)
*
|
1987-03-04 |
1989-04-14 |
Gvozdjakova Anna |
2,6-dimethylphenylcarbamoylmethylpyridiniumchloride and process for preparing thereof
|
|
GB8727504D0
(en)
|
1987-11-24 |
1987-12-23 |
Glaxo Group Ltd |
Chemical compositions
|
|
US4994213A
(en)
|
1988-05-17 |
1991-02-19 |
Liposome Technology, Inc. |
Method of preparing lipid structures
|
|
US4980378A
(en)
|
1988-06-01 |
1990-12-25 |
Odontex, Inc. |
Biodegradable absorption enhancers
|
|
US5082866A
(en)
|
1988-06-01 |
1992-01-21 |
Odontex, Inc. |
Biodegradable absorption enhancers
|
|
US5194581A
(en)
|
1989-03-09 |
1993-03-16 |
Leong Kam W |
Biodegradable poly(phosphoesters)
|
|
US5194266A
(en)
|
1989-08-08 |
1993-03-16 |
Liposome Technology, Inc. |
Amphotericin B/cholesterol sulfate composition and method
|
|
US5356633A
(en)
|
1989-10-20 |
1994-10-18 |
Liposome Technology, Inc. |
Method of treatment of inflamed tissues
|
|
DD298726A5
(de)
|
1989-12-29 |
1992-03-12 |
Biologische Zentralanstalt Berlin,De |
Fungizide mittel
|
|
DD298727A5
(de)
|
1989-12-29 |
1992-03-12 |
Biologische Zentralanstalt Berlin,De |
Mikrobizide mittel
|
|
DD298723A5
(de)
|
1989-12-29 |
1992-03-12 |
Biologische Zentralanstalt Berlin,De |
Biozide mittel
|
|
ATE139439T1
(de)
|
1991-04-19 |
1996-07-15 |
Nexstar Pharmaceuticals Inc |
Pharmazeutische formulierung und pharmazeutisches verfahren
|
|
US5176907A
(en)
|
1991-08-13 |
1993-01-05 |
The Johns Hopkins University School Of Medicine |
Biocompatible and biodegradable poly (phosphoester-urethanes)
|
|
FR2688219B1
(fr)
|
1992-03-03 |
1994-07-08 |
Sanofi Elf |
Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
|
|
GR1002207B
(en)
|
1992-08-06 |
1996-03-27 |
Johnson & Johnson Consumer |
Skin care compositions containing imidazoles.
|
|
US5552155A
(en)
|
1992-12-04 |
1996-09-03 |
The Liposome Company, Inc. |
Fusogenic lipsomes and methods for making and using same
|
|
US5480971A
(en)
|
1993-06-17 |
1996-01-02 |
Houghten Pharmaceuticals, Inc. |
Peralkylated oligopeptide mixtures
|
|
US5409805A
(en)
|
1993-07-29 |
1995-04-25 |
Konica Corporation |
Solid processing agent for silver halide photographic light-sensitive materials
|
|
US6051576A
(en)
|
1994-01-28 |
2000-04-18 |
University Of Kentucky Research Foundation |
Means to achieve sustained release of synergistic drugs by conjugation
|
|
US5591317A
(en)
|
1994-02-16 |
1997-01-07 |
Pitts, Jr.; M. Michael |
Electrostatic device for water treatment
|
|
US5716622A
(en)
|
1995-01-06 |
1998-02-10 |
The Rockefeller University |
Functionally active regions of signal transducer and activators of transcription
|
|
US5783683A
(en)
|
1995-01-10 |
1998-07-21 |
Genta Inc. |
Antisense oligonucleotides which reduce expression of the FGFRI gene
|
|
US5747470A
(en)
|
1995-06-07 |
1998-05-05 |
Gen-Probe Incorporated |
Method for inhibiting cellular proliferation using antisense oligonucleotides to gp130 mRNA
|
|
AU5938996A
(en)
|
1995-06-07 |
1996-12-30 |
Nexstar Pharmaceuticals, Inc. |
Method for encapsulating pharmaceutical materials
|
|
AU6714996A
(en)
|
1995-07-31 |
1997-02-26 |
Merck & Co., Inc. |
2-(fluorenonyl)-carbapenems, compositions and methods of use
|
|
US6413961B1
(en)
|
1995-12-12 |
2002-07-02 |
Omeros Medical Systems, Inc. |
Irrigation solution and method for inhibition of pain and inflammation
|
|
SE508357C2
(sv)
|
1996-01-02 |
1998-09-28 |
Kay Laserow |
Mätinstrument för mätning av smärta jämte ett förfarande för att med ett mätinstrument mäta smärta
|
|
WO1998024428A1
(en)
|
1996-12-02 |
1998-06-11 |
Brigham & Women's Hospital, Inc. |
Long-acting local anesthetics
|
|
SE9604751D0
(sv)
|
1996-12-20 |
1996-12-20 |
Astra Ab |
New therapy
|
|
US5837713A
(en)
|
1997-02-26 |
1998-11-17 |
Mayo Foundation For Medical Education And Research |
Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids
|
|
US6008318A
(en)
|
1997-06-18 |
1999-12-28 |
Guilford Pharmaceuticals Inc. |
Two-stage solution polymerization of high molecular weight poly(phosphoesters)
|
|
RU2105554C1
(ru)
|
1997-06-24 |
1998-02-27 |
Всероссийский научный центр по безопасности биологически активных веществ |
N-(2,4,6-триметилфенилкарбамоилметил)-n-аллилморфолиний бромид, проявляющий противоишемическое и антиаритмическое действие при ишемической болезни сердца и способ его получения
|
|
US6028163A
(en)
|
1997-06-27 |
2000-02-22 |
Guilford Pharmaceuticals Inc. |
Solution polymerization of high molecular weight poly(phosphoesters) in toluene
|
|
AU7937298A
(en)
|
1997-07-08 |
1999-02-08 |
Ono Pharmaceutical Co. Ltd. |
Amino acid derivatives
|
|
TW536401B
(en)
|
1997-09-03 |
2003-06-11 |
Cardiome Pharma Corp |
A pharmaceutical composition of N,N-bis(phenylcarbamoylmethyl)dimethylammomum chloride and derivatives for the treatment of pain
|
|
US6623040B1
(en)
|
1997-09-03 |
2003-09-23 |
Recot, Inc. |
Method for determining forced choice consumer preferences by hedonic testing
|
|
US5891919A
(en)
|
1997-09-19 |
1999-04-06 |
Burlington Bio-Medical & Scientific Corp. |
Denatonium capsaicinate and methods of producing the same
|
|
US6083996A
(en)
|
1997-11-05 |
2000-07-04 |
Nexmed Holdings, Inc. |
Topical compositions for NSAI drug delivery
|
|
US6140351A
(en)
|
1997-12-19 |
2000-10-31 |
Berlex Laboratories, Inc. |
Ortho-anthranilamide derivatives as anti-coagulants
|
|
US6207290B1
(en)
|
1998-04-07 |
2001-03-27 |
Burlington Bio-Medical & Scientific Corp. |
Antifoulant compositions and methods of treating wood
|
|
US6362197B1
(en)
|
1998-06-09 |
2002-03-26 |
Cardiome Pharma Corp. |
Compositions and method for treatment of cough
|
|
JP2000143635A
(ja)
|
1998-06-10 |
2000-05-26 |
Takeda Chem Ind Ltd |
血管新生阻害剤
|
|
US6153212A
(en)
|
1998-10-02 |
2000-11-28 |
Guilford Pharmaceuticals Inc. |
Biodegradable terephthalate polyester-poly (phosphonate) compositions, articles, and methods of using the same
|
|
FR2787706B1
(fr)
*
|
1998-12-23 |
2002-06-14 |
Oreal |
Procede de teinture mettant en oeuvre une amine cationique heterocyclique et un compose choisi parmi un aldehyde, une cetone, une quinone et un derive de la di-imino-isoindoline ou de la 3-amino-isoindolone
|
|
US7507545B2
(en)
|
1999-03-31 |
2009-03-24 |
Cardiome Pharma Corp. |
Ion channel modulating activity method
|
|
US6103255A
(en)
|
1999-04-16 |
2000-08-15 |
Rutgers, The State University |
Porous polymer scaffolds for tissue engineering
|
|
US6118020A
(en)
|
1999-05-19 |
2000-09-12 |
Nexmed Holdings, Inc. |
Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate
|
|
FR2794644B1
(fr)
*
|
1999-06-09 |
2004-04-16 |
Oreal |
Utilisation de sels d'arenediazonium et de copulants cationiques pour la teinture reactive de fibres keratiniques
|
|
EP1216242A1
(de)
|
1999-10-01 |
2002-06-26 |
Advanced Medicine, Inc. |
Macrocyclische quinazolinone und ihre verwendung als lokalanästhetika
|
|
US6608094B2
(en)
*
|
1999-10-06 |
2003-08-19 |
Torrent Pharmaceuticals Ltd. |
Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
|
|
US20020103228A1
(en)
*
|
1999-10-06 |
2002-08-01 |
Torrent Pharmaceuticals Ltd. |
Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications
|
|
MXPA02006051A
(es)
|
1999-12-15 |
2004-08-23 |
Ucb Farchim Sa |
Compuestos de amonio cuaternario ciclico.
|
|
NZ519746A
(en)
|
1999-12-15 |
2004-05-28 |
Ucb Farchim S |
Quaternary salts of N-substituted cyclic or acyclic amines as pharmaceuticals
|
|
WO2001045678A2
(de)
|
1999-12-21 |
2001-06-28 |
Id Pharma Gmbh |
Arzneimittel, verfahren zu dessen herstellung und dessen verwendung
|
|
EP1283910A4
(de)
|
2000-05-04 |
2005-03-09 |
Dzgenes Llc |
Polymorphismen des tgf-beta-rii-promotors
|
|
CA2414389A1
(en)
|
2000-06-23 |
2002-01-03 |
Mayo Foundation For Medical Education & Research |
Methods of treating neutrophil-related diseases with topical anesthetics
|
|
US20030176426A1
(en)
*
|
2000-07-13 |
2003-09-18 |
Alteon, Inc. |
Method for treating fibrotic diseases or other indications with imidazolium agents
|
|
DE10039449A1
(de)
|
2000-08-11 |
2003-07-24 |
Id Pharma Gmbh I Ins |
Verwendung einer lokalanästhetikumhaltigen Zusammensetzung zur Behandlung von Hyperalgesien
|
|
AU2002214626A1
(en)
|
2000-09-29 |
2002-04-08 |
Cor Therapeutics, Inc. |
Quaternary amines and related inhibitors of factor xa
|
|
US6766319B1
(en)
|
2000-10-31 |
2004-07-20 |
Robert J. Might |
Method and apparatus for gathering and evaluating information
|
|
US6884782B2
(en)
|
2000-11-08 |
2005-04-26 |
Amgen Inc. |
STAT modulators
|
|
JP2004521111A
(ja)
|
2001-01-25 |
2004-07-15 |
ユーロ−セルティーク，エス．エイ． |
局所麻酔薬および使用法
|
|
US20040146590A1
(en)
|
2001-03-22 |
2004-07-29 |
Iadarola Michael J |
Molecular neurochirurgie for pain control administering locally capsaicin or resinferatoxin
|
|
US20030027833A1
(en)
|
2001-05-07 |
2003-02-06 |
Cleary Gary W. |
Compositions and delivery systems for administration of a local anesthetic agent
|
|
JP4541695B2
(ja)
|
2001-06-15 |
2010-09-08 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼインヒビターとしての５−（２−アミノピリミジン−４−イル）ベンズイソキサゾール
|
|
US7157103B2
(en)
|
2001-08-06 |
2007-01-02 |
Euro-Celtique S.A. |
Pharmaceutical formulation containing irritant
|
|
US20030068276A1
(en)
|
2001-09-17 |
2003-04-10 |
Lyn Hughes |
Dosage forms
|
|
ITMI20012025A1
(it)
|
2001-09-28 |
2003-03-28 |
Dompe Spa |
Sali di ammonio quaternari di omega-amminoalchilammidi di acidi r 2-aril-propionici e composizioni farmaceutiche che li contengono
|
|
PT1534320E
(pt)
|
2002-08-02 |
2007-02-28 |
Univ Bruxelles |
Apolipoproteína l-i para o tratamento de doenças de tripanossomas
|
|
JP2006513159A
(ja)
|
2002-11-01 |
2006-04-20 |
メルク エンド カムパニー インコーポレーテッド |
アンドロゲン受容体モジュレーターとしてのカルボニルアミノ−ベンズイミダゾール誘導体
|
|
EA012599B1
(ru)
|
2003-04-10 |
2009-10-30 |
Ньюроджескс, Инк. |
Способы и композиции для введения агонистов trpv1
|
|
WO2004093814A2
(en)
|
2003-04-22 |
2004-11-04 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a sodium channel blocker
|
|
ES2223277B1
(es)
|
2003-06-19 |
2006-03-01 |
Fernando Bouffard Fita |
Composicion anestesica para administracion topica.
|
|
WO2005014849A2
(en)
|
2003-07-03 |
2005-02-17 |
Euro-Celtique, S.A. |
Genes associated with responses to neuropathic pain
|
|
US8361467B2
(en)
|
2003-07-30 |
2013-01-29 |
Depuy Spine, Inc. |
Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
|
|
NO20034069L
(no)
|
2003-09-12 |
2005-03-14 |
Aximed As |
Fremstilling og bruk av capsaicinderivater
|
|
US20070149469A1
(en)
|
2003-10-02 |
2007-06-28 |
Christian Korherr |
Medical use of tbk-1 or of inhibitors thereof
|
|
US20050142596A1
(en)
|
2003-11-14 |
2005-06-30 |
Krolewski Andrzej S. |
Methods of diagnosing renal and cardiovascular disease
|
|
EP1701941B1
(de)
|
2003-12-11 |
2012-05-30 |
Board of Regents, The University of Texas System |
Verbindungen zur behandlung von krankheiten mit zellproliferation
|
|
WO2005089206A2
(en)
|
2004-03-13 |
2005-09-29 |
Irm Llc |
Modulators of ion channel trpa1
|
|
US7161034B2
(en)
|
2004-04-20 |
2007-01-09 |
Dade Behring Inc. |
Lidocaine analogs and methods of making and using same
|
|
US20060106020A1
(en)
|
2004-04-28 |
2006-05-18 |
Rodgers James D |
Tetracyclic inhibitors of Janus kinases
|
|
US20060100272A1
(en)
|
2004-06-02 |
2006-05-11 |
Sri International |
Formulations for the treatment of pain
|
|
RU2258700C1
(ru)
|
2004-06-28 |
2005-08-20 |
Государственное образовательное учреждение высшего профессионального образования "Мордовский государственный университет им. Н.П. Огарева" |
Четвертичное аммониевое производное лидокаина, обладающее противоаритмической активностью и способ его получения
|
|
PT1781272T
(pt)
|
2004-07-24 |
2017-12-11 |
Esteve Labor Dr |
Utilização de compostos ativos no recetor sigma para o tratamento de alodinia mecânica
|
|
ITMI20041566A1
(it)
|
2004-07-30 |
2004-10-30 |
Indena Spa |
"trpv1 agonisti, formulazioni che li contengono e loro usi"
|
|
WO2006036180A1
(en)
|
2004-09-20 |
2006-04-06 |
Corus Pharma, Inc. |
Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough and tussive attacks
|
|
US7947682B2
(en)
|
2004-12-29 |
2011-05-24 |
University Of Southern California |
Substituted N′-pyrrolo[1,2-a]quinoxalin-4-yl-hydrazides as anti-cancer agents
|
|
US20090306429A1
(en)
|
2004-12-06 |
2009-12-10 |
Henk Pluim |
Preparation of a quaternary ammonium hydroxide and use thereof for the preparation of a quaternary ammonium salt
|
|
EP1824466A4
(de)
|
2004-12-16 |
2008-03-05 |
Advanced Inhalation Res Inc |
Zusammensetzungen und verfahren für lungenleiden
|
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
|
WO2006133588A1
(en)
|
2005-06-13 |
2006-12-21 |
Oncalis Ag |
ARYL UREA COMPOUNDS AS β-SECRETASE INHIBITORS
|
|
GB0517966D0
(en)
|
2005-09-02 |
2005-10-12 |
Novartis Ag |
Organic compounds
|
|
WO2007038215A1
(en)
|
2005-09-22 |
2007-04-05 |
Incyte Corporation |
Tetracyclic inhibitors of janus kinases
|
|
US8357665B2
(en)
|
2005-10-12 |
2013-01-22 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
|
|
ES2611588T3
(es)
|
2005-12-13 |
2017-05-09 |
Incyte Holdings Corporation |
Pirrolo[2,3-b]piridinas y pirrolo[2,3-b]pirimidinas sustituidas con heteroarilo como inhibidores de quinasas Janus
|
|
CA2634491A1
(en)
|
2005-12-21 |
2007-06-28 |
Painceptor Pharma Corporation |
Compositions and methods for modulating gated ion channels
|
|
GB0526244D0
(en)
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
|
EP1867338A1
(de)
|
2006-05-30 |
2007-12-19 |
Université Libre De Bruxelles |
Pharmazeutische Zusammensetzung enthaltend Apolipoproteine
|
|
KR20140097446A
(ko)
|
2006-11-20 |
2014-08-06 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
통증 및 소양증 치료용 방법, 조성물 및 키트
|
|
US8513270B2
(en)
|
2006-12-22 |
2013-08-20 |
Incyte Corporation |
Substituted heterocycles as Janus kinase inhibitors
|
|
GB0702382D0
(en)
|
2007-02-07 |
2007-03-21 |
Argenta Discovery Ltd |
New salt
|
|
ES2340640T3
(es)
|
2007-03-23 |
2010-06-07 |
Icagen, Inc. |
Inhibidores de canales de iones.
|
|
JP2010530901A
(ja)
|
2007-06-22 |
2010-09-16 |
ハイドラ バイオサイエンシズ インコーポレイテッド |
障害を治療するための方法および組成物
|
|
WO2009026107A1
(en)
|
2007-08-17 |
2009-02-26 |
Portola Pharmaceuticals, Inc. |
Protein kinase inhibitors
|
|
CN101156851A
(zh)
|
2007-09-27 |
2008-04-09 |
刘全胜 |
盐酸尼卡地平分散片及其制备方法
|
|
US20110086818A1
(en)
|
2008-03-11 |
2011-04-14 |
Presidents And Fellows Of Harvard College |
Methods, compositions, and kits for treating pain and pruritus
|
|
US8138339B2
(en)
|
2008-04-16 |
2012-03-20 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
WO2009131687A2
(en)
|
2008-04-22 |
2009-10-29 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
WO2009140519A1
(en)
|
2008-05-14 |
2009-11-19 |
Hydra Biosciences, Inc. |
Compounds and compositions for treating chemical warfare agent-induced injuries
|
|
KR20110033922A
(ko)
|
2008-07-08 |
2011-04-01 |
더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 |
전사의 신호 변환자 및 활성제（ｓｔａｔｓ）의 증식 및 활성화의 신규한 억제제
|
|
DE102008037682A1
(de)
|
2008-08-14 |
2010-04-08 |
Strackharn, Klaus, Dr.med. |
Verwendung äquipotenter Dosierungen von Lokalanästetika oder Derivaten davon zur Therapie chronischer Schmerzen
|
|
CN101347427A
(zh)
|
2008-09-22 |
2009-01-21 |
北京理工大学 |
一种沙坦化合物或其可药用盐和钙通道阻断剂或可药用盐的复方
|
|
CL2009001884A1
(es)
|
2008-10-02 |
2010-05-14 |
Incyte Holdings Corp |
Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
|
|
MX2011003625A
(es)
|
2008-10-06 |
2011-05-31 |
Idera Pharmaceuticals Inc |
Uso de inhibidores de receptores tipo toll en la prevencion y tratamiento de hipercolesterolemia e hiperlipidemia y enfermedades relacionadas con esto.
|
|
EP2411019A2
(de)
|
2009-03-27 |
2012-02-01 |
Merck Sharp&Dohme Corp. |
Rna-interferenz-vermittelte hemmung der signal transducer and activator of transcription 1 (stat1) gen-expression mittels sina (short interfering nucleic acid)
|
|
EP3485881B1
(de)
|
2009-07-10 |
2024-03-13 |
President and Fellows of Harvard College |
Permanent geladene natrium- und calciumkanalblocker als entzündungshemmende mittel
|
|
US9023355B2
(en)
|
2010-04-13 |
2015-05-05 |
Beth Israel Deaconess Medical Center, Inc. |
Compositions and methods for treating renal disease
|
|
US9828637B2
(en)
|
2010-04-18 |
2017-11-28 |
Wake Forest University Health Sciences |
Methods of predicting predisposition to or risk of kidney disease
|
|
EP2611448A1
(de)
|
2010-09-01 |
2013-07-10 |
Ambit Biosciences Corporation |
7-cyclylchinazolinderivate und verwendungsverfahren dafür
|
|
ES2573497T3
(es)
|
2011-02-02 |
2016-06-08 |
Vertex Pharmaceuticals Incorporated |
Pirrolopirazin-amidas de piperidina espirocíclicas como moduladores de canales iónicos
|
|
US9388137B2
(en)
|
2011-10-31 |
2016-07-12 |
Purdue Pharma L.P. |
Quaternized amines as sodium channel blockers
|
|
WO2013130808A1
(en)
|
2012-02-29 |
2013-09-06 |
D.E. Shaw Research, Llc |
Methods for screening voltage gated proteins
|
|
CA2881464C
(en)
|
2012-08-07 |
2021-12-21 |
Children's Medical Center Corporation |
Potassium channel openers for treating neurodegenerative diseases
|
|
US8841309B2
(en)
|
2012-09-24 |
2014-09-23 |
Boehringer Ingelheim International Gmbh |
Substituted pyrazines and their use in the treatment of disease
|
|
US8822537B2
(en)
|
2012-09-27 |
2014-09-02 |
Achelios Therapeutics, Inc. |
Topical ketoprofen composition
|
|
LV15002B
(lv)
*
|
2013-10-29 |
2015-07-20 |
Latvijas Organiskās Sintēzes Institūts |
Heterociklā aizvietoti [(2-karboksi vai -metoksikarbonil)fenilkarbamoil-metil (vai trimetilēn)] piridīnija vai izohinolīnija bromīdi kā hidroksikarbonskābju receptoru saimes (HCA2) jauna ligandu klase
|
|
CN105566148B
(zh)
|
2014-10-14 |
2017-10-03 |
沈阳中化农药化工研发有限公司 |
一种季铵盐类化合物及其应用
|
|
WO2016140942A1
(en)
|
2015-03-04 |
2016-09-09 |
The Procter & Gamble Company |
Fibrous elements, fibrous structures, and products comprising a deterrent agent and methods for making same
|
|
CN106310289B
(zh)
|
2015-06-24 |
2020-10-13 |
天津键凯科技有限公司 |
一种聚乙二醇和麻醉药的结合物及其制备方法
|
|
JP6833811B2
(ja)
*
|
2015-08-03 |
2021-02-24 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
荷電イオンチャネル遮断薬及び使用方法
|
|
DE102016009766A1
(de)
|
2016-08-11 |
2018-02-15 |
Julius-Maximilians-Universität Würzburg |
Herstellung von Bitterstoffderivaten
|
|
JOP20190245A1
(ar)
|
2017-04-20 |
2019-10-15 |
Novartis Ag |
أنظمة توصيل إطلاق مستدام تتضمن روابط بلا أثر لنقطة الربط
|
|
CN108929263B
(zh)
|
2017-05-26 |
2022-07-22 |
中国医学科学院药物研究所 |
芳酰胺类Kv2.1抑制剂及其制备方法、药物组合物和用途
|
|
US10835505B2
(en)
|
2018-06-11 |
2020-11-17 |
Aardvark Therapeutics, Inc. |
Oral pharmaceutical formulation for weight loss, diabetes and related disorders
|
|
US10780083B1
(en)
|
2019-03-11 |
2020-09-22 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
|
CA3129089A1
(en)
|
2019-03-11 |
2020-09-17 |
Bridget Mccarthy Cole |
Ester substituted ion channel blockers and methods for use
|
|
WO2020185881A1
(en)
|
2019-03-11 |
2020-09-17 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
|
US10828287B2
(en)
|
2019-03-11 |
2020-11-10 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
|
US11377422B2
(en)
|
2019-03-11 |
2022-07-05 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
|
JP2023500891A
(ja)
|
2019-11-06 |
2023-01-11 |
ノシオン セラピューティクス，インコーポレイテッド |
荷電したイオンチャンネル遮断薬および使用方法
|
|
EP4054586A4
(de)
|
2019-11-06 |
2023-11-22 |
Nocion Therapeutics, Inc. |
Geladene ionenkanalblocker und verfahren zur verwendung
|